This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

55/100

✓ Peer-reviewed alzhub usefulness score 55 out of 100. Prevention trials

Topic: Risk, prevention and care in population studies

= 0.279). No adverse events were reported. Live online exercise sessions were safe, feasible, and demonstrated adherence and intensity comparable to onsite sessions. Trial registration: The trial was registered at the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR) on November 24, 2019 (UMIN000038671) (https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044075).

Key findings

Live online exercise sessions were safe, feasible, and demonstrated adherence and intensity comparable to onsite sessions.
Trial registration: The trial was registered at the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR) on November 24, 2019 (UMIN000038671) (https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044075).

Why it matters

This study found that live online exercise sessions for older adults with mild cognitive impairment were safe and feasible, with adherence and intensity comparable to onsite sessions. It addresses how to deliver exercise, not whether exercise treats, cures or prevents Alzheimer's disease.

New to this subject? Start with our plain-English guide: Prevention →

Study details

Study designrandomized controlled trial
Evidence strengthHigh

How this study scored 55/100

Published in a peer-reviewed journal, and it is a randomised controlled trial. Scored zero for sample size, effect reported and studied in people because the record does not state it.

Component	Points	Why
Journal tier	7 / 10	Tier 3 — peer-reviewed journal (Journal of Aging Research and Lifestyle)
Journal's citation record	0 / 4	Journal of Aging Research and Lifestyle: journal h-index 13 (OpenAlex, 2026-10-29)
Study design	11 / 12	A randomised controlled trial
Strength of evidence	5 / 5	Rated “high” in our summary
Peer-review validation	10 / 10	Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent	4 / 5	2025 — within 3 year(s) of the newest study here
Sample size	0 / 4	Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported	0 / 3	No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people	0 / 3	Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded	1 / 2	Randomised (as stated in the record)
Times cited	1 / 7	Cited 3 times (OpenAlex, 2026-10-10)
Citations per year	1 / 5	1.0 citations a year over 3 year(s) since 2025
Impact for its field and year	2 / 6	Cited 1.9× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here	1 / 6	Cited by 1 other studies in this library
Still being cited	1 / 4	Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record	2 / 4	Last-listed author Takashi Sakurai: h-index 45 (OpenAlex, whole career)
Institution's track record	3 / 3	University of Washington: institution h-index 3,540 (OpenAlex)
Multi-centre collaboration	2 / 3	OpenAlex lists 4 institution(s) in 2 countries
Indexed in PubMed	2 / 2	Indexed in PubMed (PMID 40046640)
Free to read	2 / 2	Free to read
Total	55 / 100	—

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

APA 7th

Sugimoto, T., Uchida, K., Yokoyama, Y., Onoyama, A., Fujita, K., Kuroda, Y., et al. (2025). Adherence and aerobic exercise intensity in live online exercise sessions for older adults with mild cognitive impairment: Insights from the Japan-Multimodal Intervention Trial for the Prevention of Dementia. Journal of Aging Research and Lifestyle. https://doi.org/10.1016/j.jarlif.2025.100003

Vancouver

Sugimoto T, Uchida K, Yokoyama Y, Onoyama A, Fujita K, Kuroda Y, et al. Adherence and aerobic exercise intensity in live online exercise sessions for older adults with mild cognitive impairment: Insights from the Japan-Multimodal Intervention Trial for the Prevention of Dementia. Journal of Aging Research and Lifestyle. 2025. doi:10.1016/j.jarlif.2025.100003. PMID: 40046640.

BibTeX

@article{sugimoto2025-40046640,
  author  = {Sugimoto, Taiki and Uchida, Kazuaki and Yokoyama, Yoko and Onoyama, Ayaka and Fujita, Kosuke and Kuroda, Yujiro and Hinakura, Keigo and Ogawa, Susumu and others},
  title   = {{Adherence and aerobic exercise intensity in live online exercise sessions for older adults with mild cognitive impairment: Insights from the Japan-Multimodal Intervention Trial for the Prevention of Dementia}},
  journal = {Journal of Aging Research and Lifestyle},
  year    = {2025},
  doi     = {10.1016/j.jarlif.2025.100003},
  pmid    = {40046640},
  url     = {https://doi.org/10.1016/j.jarlif.2025.100003}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Prevention trials

Also tagged “cognitive-function”

1,118 studies in the library carry the topic tag “cognitive-function”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,118 tagged studies.

Similar studies

More on Prevention trials

See all studies in Prevention trials →